The popularity of Viagra initially sparked a surge for major pharmaceutical companies, but recent shifts present a complicated outlook for shareholders. Off-patent versions are reducing earnings, and persistent patent https://woodyzypg374876.webdesign96.com/41457615/sildenafil-and-pharma-a-precarious-play